Journal ArticleDOI
Gait slowing as a predictor of incident dementia: 6-year longitudinal data from the Sydney Older Persons Study.
Reads0
Chats0
TLDR
The Sydney Older Persons Study examined 6-year outcomes of 630 community-dwelling participants aged 75 or over at recruitment, finding simple measures of gait may provide useful clinical tools, assisting in the prediction of dementia.About:
This article is published in Journal of the Neurological Sciences.The article was published on 2005-03-15. It has received 252 citations till now. The article focuses on the topics: Dementia & Vascular dementia.read more
Citations
More filters
Journal ArticleDOI
The role of executive function and attention in gait
Galit Yogev-Seligmann,Galit Yogev-Seligmann,Jeffrey M. Hausdorff,Jeffrey M. Hausdorff,Jeffrey M. Hausdorff,Nir Giladi,Nir Giladi +6 more
TL;DR: The variety of gait disorders that may be associated with different aspects of executive function, and the changes occurring in executive function as a result of aging and disease as well the potential impact of these changes on gait are described.
Journal ArticleDOI
Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force
Gabor Abellan van Kan,Yves Rolland,Sandrine Andrieu,Juergen M. Bauer,Olivier Beauchet,Marc Bonnefoy,Matteo Cesari,Lorenzo M. Donini,Sophie Gillette-Guyonnet,Marco Inzitari,Fati Nourhashemi,Graziano Onder,P. Ritz,Antoni Salvà,Marjolein Visser,Bruno Vellas +15 more
TL;DR: Gait speed at usual pace was found to be a consistent risk factor for disability, cognitive impairment, institutionalisation, falls, and/or mortality in older adults as mentioned in this paper, and the use of simple, safe, and easy to perform assessment tool, like gait speed, to evaluate vulnerability to adverse outcomes in community-dwelling older people is appealing.
Journal ArticleDOI
Cognition assessment using the NIH Toolbox
Sandra Weintraub,Sureyya Dikmen,Robert K. Heaton,David S. Tulsky,Philip David Zelazo,Patricia J. Bauer,Noelle E. Carlozzi,Jerry Slotkin,David L. Blitz,Kathleen Wallner-Allen,Nathan A. Fox,Jennifer L. Beaumont,Dan M Mungas,Cindy J. Nowinski,Jennifer Richler,Joanne Deocampo,Jacob E. Anderson,Jennifer J. Manly,Beth Borosh,Richard Havlik,Kevin P. Conway,Emmeline Edwards,Lisa S. Freund,Jonathan W. King,Claudia S. Moy,Ellen D. Witt,Richard Gershon +26 more
TL;DR: The NIH-TB Cognition Battery is intended to serve as a brief, convenient set of measures to supplement other outcome measures in epidemiologic and longitudinal research and clinical trials and will provide a “common currency” among researchers for comparisons across a wide range of studies and populations.
Journal ArticleDOI
Overview and Findings from the Rush Memory and Aging Project
David A. Bennett,Julie A. Schneider,Aron S. Buchman,Lisa L. Barnes,Patricia A. Boyle,Robert S. Wilson +5 more
TL;DR: The Memory and Aging Project is a longitudinal, epidemiologic clinical-pathologic cohort study of common chronic conditions of aging with an emphasis on decline in cognitive and motor function and risk of Alzheimer's disease.
Journal ArticleDOI
Quantitative gait dysfunction and risk of cognitive decline and dementia
TL;DR: The findings indicate that quantitative gait measures predict future risk of cognitive decline and dementia in initially non-demented older adults.
References
More filters
Journal ArticleDOI
Mild Cognitive Impairment: Clinical Characterization and Outcome
Ronald C. Petersen,Glenn E. Smith,Stephen C. Waring,Robert J. Ivnik,Eric G. Tangalos,Emre Kokmen +5 more
TL;DR: Patients who meet the criteria for MCI can be differentiated from healthy control subjects and those with very mild AD, and appear to constitute a clinical entity that can be characterized for treatment interventions.
Journal ArticleDOI
Current concepts in mild cognitive impairment.
Ronald C. Petersen,Rachelle S. Doody,Alexander Kurz,Richard C. Mohs,John C. Morris,Peter V. Rabins,Karen Ritchie,Martin N. Rossor,Leon J. Thal,Bengt Winblad +9 more
TL;DR: A group of experts on aging and MCI from around the world in the fields of neurology, psychiatry, geriatrics, neuropsychology, neuroimaging, neuropathology, clinical trials, and ethics was convened to summarize the current state of the field of MCI.